CD-QAS Knowledge Base
CD-QAS (Clinical Data Quality Audit & Action System) is a web-based CBDR tool that provides HTCs with nightly refreshed, real-time centre-level data quality views and action lists for records requiring attention.
CD-QAS (Clinical Data Quality Audit & Action System) is a web-based data quality monitoring and reporting tool for the Canadian Bleeding Disorders Regi...
Mon, 30 Mar, 2026 at 1:54 PM
Patient List The Patient List is the primary demographic and clinical reference view. It presents a sortable, filterable table of all patients registered a...
Mon, 30 Mar, 2026 at 1:46 PM
The Audit & Action Lists module contains predefined lists that flag patients with specific data quality issues at each centre. Each list displays a sta...
Mon, 30 Mar, 2026 at 1:54 PM
Description This Action List flags patients aged 80 years or older who have had no system activity in the last 36 months. Activity includes any MyCBDR inte...
Mon, 30 Mar, 2026 at 1:52 PM
Description This Action List flags hemophilia patients who do not have an active treatment plan recorded in CBDR. It also indicates whether the patient has...
Mon, 30 Mar, 2026 at 1:53 PM
Description This Action List flags severe hemophilia patients whose treatment plans have not been updated in 18 or more months. Patients who have had an H...
Mon, 30 Mar, 2026 at 1:54 PM
Description This Action List flags patients across the CBDR population who do not have genetic testing data recorded. Genetic testing results are a key com...
Mon, 30 Mar, 2026 at 1:55 PM
Description This Action List flags patients who are prescribed hemophilia treatments (factor concentrates, emicizumab, or other hemophilia-specific product...
Mon, 30 Mar, 2026 at 1:55 PM
Gene therapy patients require structured monitoring over multiple years post-infusion. The Patient Timeline (Section 3) provides a single longitudinal view ...
Mon, 30 Mar, 2026 at 1:56 PM
Rebalancing agents represent a new class of therapies with specific safety monitoring requirements, particularly around thrombotic risk. As with gene therap...
Mon, 30 Mar, 2026 at 1:57 PM